The economic returns to community and hospital screening programs for a genetic disease

J. Michael Swint, Judith M. Shapiro, Virginia L. Corson, Linda W. Reynolds, George H. Thomas, Haig Kazazian

Research output: Contribution to journalArticle

Abstract

Screening and prevention programs for genetic disorders have proliferated in the United States during the past decade. The National Genetics Act is currently facilitating their continued expansion. To achieve an efficient allocation of the resources available for screening and prevention, it is necessary to evaluate competing programs. We present a methodology designed for the evaluation of the economic impact of such programs and then illustrate it by using two models for Tay - Sachs disease prevention as a case study: (a) The Johns Hopkins School of Medicine, J.F. Kennedy Institute, Tay -Sachs Disease Community Screening and Prevention Program and (b) the Johns Hopkins Hospital weekly screening program. A total of 1,902 individuals were screened, 1,358 in the community program and 544 in the hospital program. The results indicate that both programs satisfied the economic criteria used. The benefit-cost ratio for the hospital screening program ranged from 1.6 to 3.2, while it ranged from 5.0 to 10.0 for the community based program. The difference in net economic returns to the community and hospital programs was primarily due to differences in program costs. The total direct and indirect costs per person screened in the community program was approximately one-half the equivalent figure for the hospital program.

Original languageEnglish (US)
Pages (from-to)463-470
Number of pages8
JournalPreventive Medicine
Volume8
Issue number4
DOIs
StatePublished - 1979

Fingerprint

Inborn Genetic Diseases
Community Hospital
Economics
Tay-Sachs Disease
Cost-Benefit Analysis
Costs and Cost Analysis
Resource Allocation
Medicine

ASJC Scopus subject areas

  • Medicine(all)

Cite this

The economic returns to community and hospital screening programs for a genetic disease. / Swint, J. Michael; Shapiro, Judith M.; Corson, Virginia L.; Reynolds, Linda W.; Thomas, George H.; Kazazian, Haig.

In: Preventive Medicine, Vol. 8, No. 4, 1979, p. 463-470.

Research output: Contribution to journalArticle

Swint, J. Michael ; Shapiro, Judith M. ; Corson, Virginia L. ; Reynolds, Linda W. ; Thomas, George H. ; Kazazian, Haig. / The economic returns to community and hospital screening programs for a genetic disease. In: Preventive Medicine. 1979 ; Vol. 8, No. 4. pp. 463-470.
@article{6a71410e86fc42cb9202e50efaa24517,
title = "The economic returns to community and hospital screening programs for a genetic disease",
abstract = "Screening and prevention programs for genetic disorders have proliferated in the United States during the past decade. The National Genetics Act is currently facilitating their continued expansion. To achieve an efficient allocation of the resources available for screening and prevention, it is necessary to evaluate competing programs. We present a methodology designed for the evaluation of the economic impact of such programs and then illustrate it by using two models for Tay - Sachs disease prevention as a case study: (a) The Johns Hopkins School of Medicine, J.F. Kennedy Institute, Tay -Sachs Disease Community Screening and Prevention Program and (b) the Johns Hopkins Hospital weekly screening program. A total of 1,902 individuals were screened, 1,358 in the community program and 544 in the hospital program. The results indicate that both programs satisfied the economic criteria used. The benefit-cost ratio for the hospital screening program ranged from 1.6 to 3.2, while it ranged from 5.0 to 10.0 for the community based program. The difference in net economic returns to the community and hospital programs was primarily due to differences in program costs. The total direct and indirect costs per person screened in the community program was approximately one-half the equivalent figure for the hospital program.",
author = "Swint, {J. Michael} and Shapiro, {Judith M.} and Corson, {Virginia L.} and Reynolds, {Linda W.} and Thomas, {George H.} and Haig Kazazian",
year = "1979",
doi = "10.1016/0091-7435(79)90320-7",
language = "English (US)",
volume = "8",
pages = "463--470",
journal = "Preventive Medicine",
issn = "0091-7435",
publisher = "Academic Press Inc.",
number = "4",

}

TY - JOUR

T1 - The economic returns to community and hospital screening programs for a genetic disease

AU - Swint, J. Michael

AU - Shapiro, Judith M.

AU - Corson, Virginia L.

AU - Reynolds, Linda W.

AU - Thomas, George H.

AU - Kazazian, Haig

PY - 1979

Y1 - 1979

N2 - Screening and prevention programs for genetic disorders have proliferated in the United States during the past decade. The National Genetics Act is currently facilitating their continued expansion. To achieve an efficient allocation of the resources available for screening and prevention, it is necessary to evaluate competing programs. We present a methodology designed for the evaluation of the economic impact of such programs and then illustrate it by using two models for Tay - Sachs disease prevention as a case study: (a) The Johns Hopkins School of Medicine, J.F. Kennedy Institute, Tay -Sachs Disease Community Screening and Prevention Program and (b) the Johns Hopkins Hospital weekly screening program. A total of 1,902 individuals were screened, 1,358 in the community program and 544 in the hospital program. The results indicate that both programs satisfied the economic criteria used. The benefit-cost ratio for the hospital screening program ranged from 1.6 to 3.2, while it ranged from 5.0 to 10.0 for the community based program. The difference in net economic returns to the community and hospital programs was primarily due to differences in program costs. The total direct and indirect costs per person screened in the community program was approximately one-half the equivalent figure for the hospital program.

AB - Screening and prevention programs for genetic disorders have proliferated in the United States during the past decade. The National Genetics Act is currently facilitating their continued expansion. To achieve an efficient allocation of the resources available for screening and prevention, it is necessary to evaluate competing programs. We present a methodology designed for the evaluation of the economic impact of such programs and then illustrate it by using two models for Tay - Sachs disease prevention as a case study: (a) The Johns Hopkins School of Medicine, J.F. Kennedy Institute, Tay -Sachs Disease Community Screening and Prevention Program and (b) the Johns Hopkins Hospital weekly screening program. A total of 1,902 individuals were screened, 1,358 in the community program and 544 in the hospital program. The results indicate that both programs satisfied the economic criteria used. The benefit-cost ratio for the hospital screening program ranged from 1.6 to 3.2, while it ranged from 5.0 to 10.0 for the community based program. The difference in net economic returns to the community and hospital programs was primarily due to differences in program costs. The total direct and indirect costs per person screened in the community program was approximately one-half the equivalent figure for the hospital program.

UR - http://www.scopus.com/inward/record.url?scp=0018747761&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018747761&partnerID=8YFLogxK

U2 - 10.1016/0091-7435(79)90320-7

DO - 10.1016/0091-7435(79)90320-7

M3 - Article

C2 - 112594

AN - SCOPUS:0018747761

VL - 8

SP - 463

EP - 470

JO - Preventive Medicine

JF - Preventive Medicine

SN - 0091-7435

IS - 4

ER -